Annual monitoring thereafter suffices for most patients with normal baseline function, though those with pre-existing liver or kidney conditions may benefit from semi-annual assessments
The study published in JAMA Psychiatry found that patients with alcohol use disorder (AUD) who were prescribed GLP-1 drugs, popularly known by their brand names Ozempic and Wegovy, had a significantly lower risk of hospitalization for alcohol-related issues
Tantiphlachiva K, Rao P, Attaluri A, et al
[1] This formulation is designed for intranasal delivery in research environments, enabling controlled investigation of peptide absorption and receptor interaction across mucosal surfaces
For patients with type 2 diabetes, 59% were treated with a single oral antidiabetic drug, 23% had known diabetes but were on no antidiabetic drug and 6% were newly diagnosed during the screening procedure
Patients must be 19 years or older